|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.244 SEK | -1.43% |
|
+3.67% | -36.85% |
| 05-06 | IRLAB Q1 operating result swings to profit of SEK 10.7 mln | RE |
| 05-06 | Irlab reports growth in revenue and operating profit | FW |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 11.63M | ||
| 28.37x | 16.94x | 0.58x | 10.33x | 21.27x | 21.77x | 0.7% | 862B | ||
| 23.66x | 5.96x | -1.56x | 5.46x | 14.85x | 16.42x | 2.41% | 533B | ||
| 24.72x | -2703.01x | 0.1x | 6.13x | 12.48x | 12.89x | 3.38% | 358B | ||
| 16.88x | 6.2x | 0.94x | 4.23x | 10.43x | 11.82x | 3.14% | 328B | ||
| 23.18x | 5.28x | 1.08x | 4.81x | 13.69x | 14.43x | 1.8% | 286B | ||
| 20.19x | 5.86x | 40.22x | 5.45x | 13.25x | 14.44x | 3.08% | 279B | ||
| 49.65x | 5.65x | -0.72x | 4.63x | 17.32x | 23.63x | 2.99% | 275B | ||
| 13.62x | 5.89x | -3.13x | 4.97x | 10.19x | 12x | 3.72% | 210B | ||
| 21.19x | 14.71x | 2.28x | 5.8x | 10.07x | 13.26x | 3.06% | 178B | ||
| -48.25x | 8.33x | 0.34x | 5.76x | 32.18x | 64.89x | 2.43% | 166B | ||
| 12.07x | 1.68x | 0.21x | 3.17x | 7.66x | 8.96x | 6.79% | 147B | ||
| 10.93x | 4.84x | 0.23x | 3.01x | 8.04x | 8.71x | 4.52% | 114B | ||
| 24.92x | 4.83x | 1.78x | 7.37x | 16.63x | 17.31x | -.--% | 110B | ||
| 10.69x | 1.18x | 1.51x | 2.14x | 6.95x | 7.55x | 5.86% | 104B | ||
| 11.55x | 3.99x | 0.88x | 2.55x | 7.48x | 8.41x | 3.79% | 100B | ||
| 25.64x | 5.83x | 1.45x | 8.77x | 16.49x | 17.3x | 1.72% | 83.36B | ||
| 38.09x | 5.14x | 2x | 8.58x | 28.48x | 29.5x | 0.51% | 52.3B | ||
| 45.94x | 1.14x | 0.71x | 2.67x | 9.85x | 27.93x | 3.87% | 51.94B | ||
| Average | 19.61x | -144.42x | 2.72x | 5.32x | 14.29x | 18.40x | 2.99% | 223.03B | |
| Weighted average by Cap. | 21.37x | -220.88x | 2.81x | 6.14x | 15.22x | 18.07x | 2.58% |
- Stock Market
- Equities
- IRLAB A Stock
- Sector IRLAB Therapeutics AB
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















